Evidence map›Paper›PMID 30213503›Full record

ReviewAlcohol (Fayetteville, N.Y.)2018

Cross-species molecular dissection across alcohol behavioral domains.

Sean P Farris, Brien P Riley, Robert W Williams, Megan K Mulligan, Michael F Miles, Marcelo F Lopez, Robert Hitzemann, Ovidiu D Iancu, Alexander Colville, Nicole A R Walter and 8 more

Open access · greenAbstract readReview
In one paragraph

Review in Alcohol (Fayetteville, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Sean P FarrisUniversity of Texas at Austin, Austin, TX, United States.
Brien P RileyVirginia Commonwealth University, Richmond, VA, United States.
Robert W WilliamsUniversity of Tennessee Health Science Center, Memphis, TN, United States.
Megan K MulliganUniversity of Tennessee Health Science Center, Memphis, TN, United States.
Michael F MilesUniversity of Tennessee Health Science Center, Memphis, TN, United States.
Marcelo F LopezUniversity of Tennessee Health Science Center, Memphis, TN, United States.
Robert HitzemannOregon Health and Science University, Portland, OR, United States.
Ovidiu D IancuOregon Health and Science University, Portland, OR, United States.
Alexander ColvilleOregon Health and Science University, Portland, OR, United States.
Nicole A R WalterOregon Health and Science University, Portland, OR, United States.
Priscila DarakjianOregon Health and Science University, Portland, OR, United States.
Denesa L OberbeckOregon Health and Science University, Portland, OR, United States.
James B DaunaisWake Forest School of Medicine, Winston-Salem, NC, United States.
Christina L ZhengOregon Health and Science University, Portland, OR, United States.
Robert P SearlesOregon Health and Science University, Portland, OR, United States.
Shannon K McWeeneyOregon Health and Science University, Portland, OR, United States.
Kathleen A GrantOregon Health and Science University, Portland, OR, United States.
R Dayne MayfieldUniversity of Texas at Austin, Austin, TX, United States. Electronic address: dayne.mayfield@austin.utexas.edu.
Oregon Health & Science University · USUniversity of Tennessee Health Science Center · USThe University of Texas at Austin · USVirginia Commonwealth University · USWake Forest University · US

Funding

TREATING ETHANOL WITHDRAWAL WITH LORAZEPAM/NALTREXONEP50AA010761 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HOWARD C. BECKER · 1996 to 2026
$46.8M
Translational measures of risk for excessive alcohol consumptionP60AA010760 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI TAMARA J. PHILLIPS · 2006 to 2026
$34.5M
Project 5 - Genetic architecture of alcohol use disorder using cross-trait genetic correlations and public next-generation sequencing studiesP50AA022537 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI JILL C BETTINGER · 2014 to 2026
$19.6M
Stress and Ethanol Self-Administration in MonkeysU01AA013510 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KATHLEEN A GRANT · 2002 to 2026
$11.8M
GENE EXPRESSION IN THE HUMAN ALCOHOLIC BRAINR01AA012404 · NIAAA · UNIVERSITY OF TEXAS AUSTIN · PI MAYFIELD, ROY DAYNE · 2000 to 2025
$10.7M
THERMAL AND METABOLIC DYSFUNCTION DURING WITHDRAWALP50AA010760 · NIAAA · OREGON HEALTH AND SCIENCE UNIVERSITY · PI CRABBE, JOHN C. · 1996 to 2005
$10.7M
Monkey Alcohol Tissue Research Resource (MATRR)R24AA019431 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Mary Lauren Benton, Verginia Carmella Cuzon Carlson · 2010 to 2026
$10.3M
Brain Tissue Resource Centre for Alcohol ResearchR28AA012725 · NIAAA · UNIVERSITY OF SYDNEY · PI Greg Trevor Sutherland · 2012 to 2026
$7.0M
Next Generation Sequencing of Human Alcoholic BrainU01AA020926 · NIAAA · UNIVERSITY OF TEXAS AT AUSTIN · PI Roy DAYNE MAYFIELD · 2011 to 2026
$6.7M
An Alcohol Affected Sib Pair Study of Alcohol DependenceR37AA011408 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI KENDLER, KENNETH SEEDMAN · 2007 to 2016
$6.5M
Neurocircuitry Mapping and Genotyping CoreU01AA013484 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI HITZEMANN, ROBERT J. · 2001 to 2021
$6.2M
Systems Genetics of Alcohol Response and Stress Effects in CNSU01AA013499 · NIAAA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WILLIAMS, ROBERT W. · 2002 to 2016
$4.8M
NIAAA NIH HHS K99 AA024836NIAAA NIH HHS P20 AA017828NIAAA NIH HHS P50 AA010760NIAAA NIH HHS P50 AA010761NIAAA NIH HHS P50 AA022537NIAAA NIH HHS P60 AA010760NIAAA NIH HHS R00 AA024836NIAAA NIH HHS R01 AA012404NIAAA NIH HHS R13 AA017581NIAAA NIH HHS R24 AA019431NIAAA NIH HHS R24 AA020245NIAAA NIH HHS R28 AA012725NIAAA NIH HHS R37 AA011408NIAAA NIH HHS U01 AA013484NIAAA NIH HHS U01 AA013499NIAAA NIH HHS U01 AA013510NIAAA NIH HHS U01 AA016662NIAAA NIH HHS U01 AA016667NIAAA NIH HHS U01 AA020926NIAAA NIH HHS U24 AA020929
6 · The paper itself

Abstract

This review summarizes the proceedings of a symposium presented at the "Alcoholism and Stress: A Framework for Future Treatment Strategies" conference held in Volterra, Italy on May 9-12, 2017. Psychiatric diseases, including alcohol-use disorders (AUDs), are influenced through complex interactions of genes, neurobiological pathways, and environmental influences. A better understanding of the common neurobiological mechanisms underlying an AUD necessitates an integrative approach, involving a systematic assessment of diverse species and phenotype measures. As part of the World Congress on Stress and Alcoholism, this symposium provided a detailed account of current strategies to identify mechanisms underlying the development and progression of AUDs. Dr. Sean Farris discussed the integration and organization of transcriptome and postmortem human brain data to identify brain regional- and cell type-specific differences related to excessive alcohol consumption that are conserved across species. Dr. Brien Riley presented the results of a genome-wide association study of DSM-IV alcohol dependence; although replication of genetic associations with alcohol phenotypes in humans remains challenging, model organism studies show that COL6A3, KLF12, and RYR3 affect behavioral responses to ethanol, and provide substantial evidence for their role in human alcohol-related traits. Dr. Rob Williams expanded upon the systematic characterization of extensive genetic-genomic resources for quantifying and clarifying phenotypes across species that are relevant to precision medicine in human disease. The symposium concluded with Dr. Robert Hitzemann's description of transcriptome studies in a mouse model selectively bred for high alcohol ("binge-like") consumption and a non-human primate model of long-term alcohol consumption. Together, the different components of this session provided an overview of systems-based approaches that are pioneering the experimental prioritization and validation of novel genes and gene networks linked with a range of behavioral phenotypes associated with stress and AUDs.

Indexed as

Alcohol DrinkingAlcohol-Related DisordersAnimalsCollagen Type VIDisease Models, AnimalGene ExpressionGene Expression ProfilingGenome-Wide Association StudyHumansKruppel-Like Transcription FactorsMacacaMiceRyanodine Receptor Calcium Release ChannelCollagen Type VIKruppel-Like Transcription FactorsRyanodine Receptor Calcium Release ChannelAlcohol-use disorderCo-expression networksGenome-wide association studyRecombinant inbred miceRNA-SeqSpecies conservationSystems biologyTranscriptome

Identifiers

PMID30213503
PMCPMC6309876
OpenAlexW2774609083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.